SAHMRI Annual Scientific Meeting 2018

Eadie, L. (Participant)

Activity: Other

Description

Tavakoli PS, Eadie LN, Heatley SL, White DW.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Poster Presentation
Adelaide, South Australia
Period25 Oct 201826 Oct 2018